发明申请
US20050129688A1 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants
有权
针对人B7.1和/或B7.2的灵长类形式的特异性猴单克隆抗体,含有其的药物组合物及其作为免疫抑制剂的用途
- 专利标题: Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants
- 专利标题(中): 针对人B7.1和/或B7.2的灵长类形式的特异性猴单克隆抗体,含有其的药物组合物及其作为免疫抑制剂的用途
-
申请号: US10986780申请日: 2004-11-15
-
公开(公告)号: US20050129688A1公开(公告)日: 2005-06-16
- 发明人: Darrell Anderson , Peter Brams , Nabil Hanna , William Shestowsky , Cheryl Heard
- 申请人: Darrell Anderson , Peter Brams , Nabil Hanna , William Shestowsky , Cheryl Heard
- 申请人地址: US CA San Diego
- 专利权人: Biogen IDEC Inc.
- 当前专利权人: Biogen IDEC Inc.
- 当前专利权人地址: US CA San Diego
- 主分类号: C12N15/02
- IPC分类号: C12N15/02 ; A61K38/00 ; A61K39/395 ; A61P17/00 ; A61P29/00 ; A61P35/00 ; A61P37/00 ; C07K14/705 ; C07K16/18 ; C07K16/28 ; C12N5/10 ; C12N15/09 ; C12P21/08 ; C07K16/44 ; C12N5/06
摘要:
The present invention relates to the identification of macaque antibodies to human B7.1 and B7.2 by screening of phage display libraries or monkey heterohybridomas obtained using B lymphocytes from B7.1 and/or B7.2 immunized monkeys. More specifically, the invention provides four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effective immunosuppressants. The invention further provides the complete DNA and amino acid sequences of the light and heavy chain of three primatized antibodies derived from those monkey monoclonal antibodies which bind B7.1 and possibly B7.2, primatized 7C10, primatized 7B6 and primatized 16C10. These primatized and monkey antibodies may be used as specific immunosuppressants, e.g., for the treatment of autoimmune diseases and to prevent organ transplant rejection.
公开/授权文献
- US07323170B2 Anti-CD80 antibodies 公开/授权日:2008-01-29
信息查询
IPC分类: